We report the case of a 65-yr-old 
Fixed drug eruption associated with anaesthesia
Thiopentone has occasionally been associated with anaphylaxis. ,-4 Such an incident can be so catastrophic that there are several reports describing the use of either skin testing or radioimmunoassay (RIA) to avert anaphylaxis .in subsequent surgery in these individuals or to conf,'rn the drug as the major cause of death from a medicolegal standpoint. 5, 6 A less well-documented event associated with thiopentone use is the eruption of discreet, well-demarcated plaques. 7,8 Classically, these eruptions appear symmetrical, may be fluid-fdled, are painful and erythematous. The lesions become evident within 24 hr of drug administration and fade within a few weeks, leaving no trace. As the appearance of this adverse effect is delayed and its course self-limiting and non-fatal, anaesthetists are seldom aware a reaction has ocetm~.
This report describes a patient who developed such a fixed drug eruption within 24 hr of receiving thiopentone anaesthesia while undergoing bronchoscopy. She subsequently required a lobectomy, necessitating the use of an alternative anaesthetic technique.
Case report
The patient, a 65-yr-old woman, ASA II, was referred for a bronchoscopy and biopsy. She had a 45-pack years smoking habit, drank considerably and was allergic to penicillin. The patient denied taking aeetaminophen, codeine, tetracycline or sulphonamides in the weeks prior to surgery. For prophylaxis, she was prescribed vancomycin 500 mg/v. Premedication consisted of lorazepam 0.5 gg sublingually and atropine 0.4 mg. Anaesthesia was induced with thiopentone 275 mg and sufentanil 20 mg. Vecuronium 6 mg was given to facilitate relaxation and 0.5-1% isoflurane to maintain anaesthesia. The patient tolerated the 30 min procedure well, left the recovery suite in good condition and was discharged from the hospital that evening.
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The next day, the patient travelled to Florida and during the flight, her fingers became swollen, erythematous and developed fluid-fdled vesicles (Figure 1) . By the time she reached her destination, her fingers were immobile and blisters were erupting temporally and periorbitally about the face. A local dermatologist diagnosed a toxic drug reaction from an unknown agent and prescribed flucinonide cream 0.05%. Application of cream improved the condition of her hands and face to the point that there was no noticeable scarring but only a residual demarcation of the affected area seven days later ( Figure   2 ).
The woman returned home and was admitted for probable lobectomy. Glycopyrrolate 0.2 I~g was employed for premeditation, anaesthesia was induced with propofol I00 mg and fentanyl given to a total of 200 ~g. Pancuronium 5 mg facilitated intubation and anaesthesia was maintained with 1-2% isoflurane. The patient tolerated the procedure well and was transferred to the Acute Care Unit for postoperative care. Following a rapid recovery and no adverse sequelae from medications administered, the patient was discharged home. 
Discussion
The close temporal association between anaesthesia and the fixed drug eruption suggests that one of the agents used was responsible. Since no documented cases of such a reaction occurring with the use of vecuronium, sufentanil or isoflurane could be found, the implication was that thiopentone may have been the causative agent. In addition, the patient denied using any agents 8 notorious for precipitating this type of reaction in the week prior to surgery.
Desmeules 8 described a non-pigmenting, fixed drug eruption which he attributed to the use of thiopentone. Our patient's detailed description and informative photographs of her experience, which closely matched Desmeules' report, coupled with the provisional diagnosis presumed by the dermatologist of fixed drug eruption, heightened our suspicion. Butler et al. 7 also reported the eruption of skin lesions on the hands, arms and legs of a patient who received thiopentone anaesthesia. In neither report was the patient challenged with thiopentone to confwm allergy, although both authors felt that testing would establish proof. The practitioners were reluctant to have their patients undergo any further discomfort.
Our patient would not consent to skin testing (either prick or intradermal), to confu-m sensitivity to thiopentone before the second operation. Fisher et al. 6 suggest examining sera for the presence of specific immunoglobulin E (IgE) antibodies in cases of anaphylaxis. In such eases, patients' reactions are characterized by cardiovas-FIGURE 2 Appearance of fingers after one week of treatment with flucinonide cream (0,05%). Note darkened are, as about the cuticles and knuckles which were once vesicular plaques. cular collapse, bronchospasm, generalized urticaria and lobster-red skin, 1-3 so a confirmation of hypersensitivity is imperative. In our patient's case, the reaction was localized. Nevertheless, some guidance in management for subsequent surgery was desirable. Williamson 9 described the successful use of propofol in a 30-yr-old woman who had had a previous anaphylactic response to thiopentone. He mentioned that there was no existing evidence of eross-aUergy between the two drugs.
This case is documented to increase awareness that fixed drug eruptions can be associated with anaesthesia. Though rare, this delayed onset reaction may be underreported 7,s as the physician prescribing the offending agent is usually not the one who is later called upon to make the diagnosis. Once recognized, further patient discomfort can be prevented by excluding the precipitating agent in future techniques.
